BioSpace News Archive

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced research revealing structures of the metabotropic glutamate receptor 2 in complex with one of Addex’s mGlu2 positive allosteric modulators.

It is estimated to grow at a CAGR of 7.6% from 2020 to 2027.

The medical equipment maintenance market expected to be US$ 16,943.29 Mn in 2018 and is predicted to grow at a CAGR of 9.0% during the forecast period 2019 - 2027, to reach US$ 36,525.26 Mn by 2027.

The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with the restraints that are impacting its growth.

iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters’ over-allotment option in connection with the Company’s initial public offering (the “IPO”).

By studying a type of immune cells called T cells, a team of Gladstone scientists has uncovered fundamental differences between patients who overcome severe COVID-19 and those who succumb to it.

PharmaForce International recently published a benchmarking report that profiles over forty of the leading Oncology Sales and Marketing organizations in the United States.

The X-ray photoelectron spectroscopy market was valued at US$ 554.07 million in 2019 and is expected to grow at a CAGR of 6.2% from 2020 to 2027 to reach US$ 896.90 million by 2027.

Children’s Hospital of Philadelphia appointed Gil Binenbaum, MD MSCE as Chief of the Division of Ophthalmology.

Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company’s Board of Directors has appointed Jerry McLaughlin as Chief Executive Officer and a member of the Board.